| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |